Английская Википедия:AB-PINACA

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

AB-PINACA is a compound that was first identified as a component of synthetic cannabis products in Japan in 2012.[1]

It was originally developed by Pfizer in 2009 as an analgesic medication.[2][3]

AB-PINACA acts as a potent agonist for the CB1 receptor (Ki = 2.87 nM, EC50 = 1.2 nM) and CB2 receptor (Ki = 0.88 nM, EC50 = 2.5 nM) and fully substitutes for Δ9-THC in rat discrimination studies, while being 1.5x more potent.[4][5]

There have been a number of reported cases of deaths and hospitalizations in relation to this synthetic cannabinoid.[6][7]

Legal status

Germany

AB-PINACA is an Anlage II controlled substance in Germany as of November 2014.[8]

Singapore

It is listed in the Fifth Schedule of the Misuse of Drugs Act and so is illegal in Singapore, as of May 2015.[9]

United States

It is a Schedule I controlled substance in the United States.[10]

China

It is a controlled substance in China as of October 2015.[11]

France

It is a controlled substance in France as of March 2017.[12]

See also

Шаблон:Div col

Шаблон:Div col end

References

Шаблон:Reflist

Шаблон:Cannabinoids